RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Peter Jackson

A collection of news and information related to Peter Jackson published by this site and its partners.
Recent News Coverage on Bristol Myers Squibb Company - Baltimore Sun
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Bristol Myers Squibb Company

A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.

Top Bristol Myers Squibb Company Articles see all

Displaying items 1-5
  • GlaxoSmithKline to acquire Human Genome Sciences

    GlaxoSmithKline to acquire Human Genome Sciences
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
  • Many executives delivered 'bang for the buck'

    For 2004, a year that saw the shares of T. Rowe Price Group Inc. surge more than 31 percent, company chief executive George A. Roche received a more modest 21.7 percent bump in his compensation - just about all from performance bonuses. In short, a half-...

    Lexicon Pharma's diabetes drug successful in mid-stage study

    (Reuters) - Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes reduced the use of insulin at meal times in a mid-stage study of patients with type 1 diabetes, sending the company's shares up as much as 17 percent. Lexicon said the...

    Immune-Checkpoint Inhibitors: Cancer Breakthrough?

    In the summer of 2012, a year after his wife had died of lung cancer, Michael Harris scraped open an old mole on his back and it would not stop bleeding. The doctors said he had stage 4 melanoma, with a virtually inoperable tumor, and that patients in his...

    Baxter to split into two companies, spin off biotech

    Baxter to split into two companies, spin off biotech
    Baxter International Inc. said Thursday it plans to spin off its $6 billion per year biopharmaceutical unit into a separate, publicly traded company by the middle of next year, following a familiar path forged by many of its peers. Shares of the the...